Literature DB >> 6139837

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

L M Gunne, J E Häggström.   

Abstract

Following eight monthly haloperidol decanoate injections rats showed an increased rate of vacuous chewing movements (VCM's), which gradually disappeared within 4 drug-free months. Another single dose of non-decanoate haloperidol reinstated a second increase in VCM rate which was still significant after 2 months. The glutamic acid decarboxylase (GAD) activity in the substantia nigra of these chronically haloperidol-treated rats was lower than untreated controls. Furthermore, there was a significant negative correlation between individual VCM rates and nigral GAD activity. No corresponding changes occurred in other brain regions. The depression of nigral GAD may reflect a reduced tissue density of GABA-ergic axon terminals within the descending striato-nigral pathway.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139837     DOI: 10.1007/bf00427260

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients.

Authors:  K G Lloyd; H Möhler; P Heitz; G Bartholini
Journal:  J Neurochem       Date:  1975-12       Impact factor: 5.372

2.  Properties of L-glutamate decarboxylase from brains of adult and newborn mice.

Authors:  J Y Wu; E Wong; K Saito; E Roberts; A Schousboe
Journal:  J Neurochem       Date:  1976-09       Impact factor: 5.372

3.  Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.

Authors:  K G Lloyd; O Hornykiewics
Journal:  Life Sci       Date:  1977-11-15       Impact factor: 5.037

4.  Brain glutamic acid decarboxylase activity in Parkinson's disease.

Authors:  U K Rinne; H Laaksonen; P Riekkinen; V Sonninen
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

5.  Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.

Authors:  K Gale
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

6.  Development of acute dystonia and tardive dyskinesia in cebus monkeys.

Authors:  S Bárány; A Ingvast; L M Gunne
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-08

7.  The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry.

Authors:  C E Ribak; J E Vaughn; E Roberts
Journal:  J Comp Neurol       Date:  1979-09-15       Impact factor: 3.215

8.  Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.

Authors:  L M Gunne; J Growdon; B Glaeser
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.

Authors:  R B Glassman; H N Glassman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Effect of haloperidol on glutamate decarboxylase activity in discrete brain areas of the rat.

Authors:  M Itoh
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  26 in total

1.  Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.

Authors:  Ian E J De Souza; Niamh M Dawson; Jeremiah J Clifford; John L Waddington; Gloria E Meredith
Journal:  Psychopharmacology (Berl)       Date:  2003-06-27       Impact factor: 4.530

Review 2.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.

Authors:  G Ellison; P Johansson; E Levin; R See; L Gunne
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  Biochemical and behavioural properties of clozapine.

Authors:  D M Coward; A Imperato; S Urwyler; T G White
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia.

Authors:  G Ellison; R E See
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

Authors:  R E See; G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.

Authors:  P Johansson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  High frequency oral movements induced by long-term administration of amperozide but not FG5803 in rats.

Authors:  U Liminga; P E Andren; L S Ohlund; L M Gunne
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

Review 10.  Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.

Authors:  R Beresford; A Ward
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.